|
1
|
Higano CS, Armstrong AJ, Sartor O, Vogelzang NJ, Kantoff PW, McLeod DG, Pieczonka CM, Penson DF, Shore ND, Vacirca J, Concepcion RS, Tutrone RF, Nordquist LT, Quinn DI, Kassabian V, Scholz MC, Harmon M, Tyler RC, Chang NN, Tang H, Cooperberg MR. Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data. Cancer 2020; 126:2935-2937. [PMID: 32154908 PMCID: PMC7935468 DOI: 10.1002/cncr.32785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Celestia S. Higano
- Division of Medical Oncology, Departments of Medicine and
Urology, University of Washington and Fred Hutchinson Cancer Research Center,
Seattle, WA, USA
| | - Andrew J. Armstrong
- Divisions of Medical Oncology and Urology, Duke University
Medical Center, Duke Cancer Institute, Duke University, Durham, NC, USA
| | - Oliver Sartor
- Section of Hematology & Medical Oncology, Department of
Medicine, Tulane Cancer Center and Tulane University School of Medicine, New
Orleans, LA, USA
| | - Nicholas J. Vogelzang
- Division of Hematology/Oncology, Comprehensive Cancer
Centers of Nevada, Las Vegas, NV, USA
| | - Philip W. Kantoff
- Department of Medicine, Memorial Sloan Kettering Cancer
Center and Weill Cornell Medical College, New York, NY, USA
| | - David G. McLeod
- Department of Surgery, Center for Prostate Disease Research
at the Uniformed Services of Health Sciences and the Walter Reed National Military
Medical Center, Bethesda, MD, USA
| | | | - David F. Penson
- Departments of Urologic Surgery and Health Policy,
Vanderbilt University Medical Center, Nashville, TN, USA
| | - Neal D. Shore
- Department of Urology, Carolina Urologic Research Center,
Myrtle Beach, SC, USA
| | | | | | | | | | - David I. Quinn
- Division of Medical Oncology, Norris Comprehensive Cancer
Center, University of Southern California, Los Angeles, CA, USA
| | | | - Mark C. Scholz
- Prostate Cancer Research Institute, Marina del Rey, CA,
USA
| | - Matt Harmon
- Dendreon Pharmaceuticals LLC, Seattle, WA, USA
| | | | | | - Hong Tang
- Dendreon Pharmaceuticals LLC, Seattle, WA, USA
| | - Matthew R. Cooperberg
- Departments of Urology and Epidemiology &
Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of
California San Francisco, San Francisco, CA, USA
| |
Collapse
|